Clinical Trial Update: Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 efficacy study evaluating Thymosin alpha1 in combination with Pegylated Interferon-alpha2a for Chronic Hepatitis B; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegylated Interferon-alpha2a (pegylated interferon alfa-2a)
• Thymosin alpha1 (thymosin alpha-1)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED